Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer.

De Laere B, Rajan P, Grönberg H, Dirix L, Lindberg J, CORE-ARV-CTC and ProBIO Investigators

JAMA Oncol 5 (7) 1060-1062 [2019-07-01; online 2019-05-03]

Clinical Genomics Stockholm [Service]

QC bibliography QC xrefs

PubMed 31046065

DOI 10.1001/jamaoncol.2019.0869

Crossref 10.1001/jamaoncol.2019.0869

2732501

pmc PMC6499126